Navigation Links
Pharmasset Reports Fiscal First Quarter 2011 Financial Results
Date:2/7/2011

PRINCETON, N.J., Feb. 7, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported financial results and operational highlights for the quarter ended December 31, 2010.

Financial ResultsRevenues were $0.2 million during the quarter ended December 31, 2010 compared to $0.3 million for the quarter ended December 31, 2009 and include amortization of up-front and subsequent collaborative and license payments received from Roche.

Net cash used in operating activities during the three months ended December 31, 2010 was $24.0 million. Pharmasset held $102.7 million in cash and cash equivalents as of December 31, 2010. On January 26, 2011, we completed a common stock offering raising an additional $123.4 million.

Total operating expenses for the quarter ended December 31, 2010 were $23.8 million as compared to $13.4 million for the same period in 2009. The increase in operating expenses for the quarter ended December 31, 2010 was primarily the result of preclinical and clinical trial costs for PSI-7977 and PSI-938 of which $5.9 million was related to API manufacturing (and related drug supply) costs and pegylated interferon and ribavirin costs for the studies of PSI-7977 and PSI-938.

Pharmasset reported a net loss of $23.5 million, or $0.69 per share, for the quarter ended December 31, 2010, as compared to a net loss of $13.9 million, or $0.49 per share, for the quarter ended December 31, 2009.

Recent Operational Highlights:-- Presented final Phase 2a results with PSI-7977 at the American Association for the Study of Liver Diseases (AASLD) in October 2010

-- Initiated Part 2 of a Phase 1 study that includes combinations of PSI-7977 and PSI-938

-- Roche reported 12 week interim results f
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... SUNNYVALE, Calif., May 1, 2015 Pharmacyclics, Inc. ... results for the quarter ended March 31, 2015, as ... merger with AbbVie Inc., no conference call will be held. ... the quarter ended March 31, 2015 increased to $206 ... 31, 2014. , Worldwide IMBRUVICA ® (ibrutinib) ...
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, ... assessment company that develops, manufactures and markets products that ... diseases, today reported financial results for the first quarter ... first quarter of 2015, Semler reported continued progress with ... over quarter revenue growth of 14%," said Doug ...
(Date:5/1/2015)... CITY, Calif. , May 1, 2015  AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies ... announced that Timothy E. Morris , chief financial ...  Details of the events are as follows: ... May 5 Location:  The Omni Berkshire Place, ...
Breaking Medicine Technology:Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4
... 27, 2011 PDI, Inc. (Nasdaq: PDII ) ... financial results on Wednesday, November 9, 2011 after the market ... at 8:30 am Eastern time to discuss the results.Access information:Date: ... numbers: , (866) 644-4654 (U.S. and Canada) or (706) 643-1203 ...
... . (NYSE: CRY ), a leading tissue processing ... announced today its results for the third quarter and first ... 4 percent to a record $29.7 million compared to $28.4 ... first nine months increased 2 percent to a record $89.2 ...
Cached Medicine Technology:CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 2CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 3CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 4CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 5CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 6CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 7CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 8CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 9CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 10CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 11CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 12CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 13CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 14CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 15CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 16CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011 17
(Date:5/2/2015)... May 02, 2015 “ ActOn ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... get connected with organizations to make a difference. , In ... very few things that aren’t about money, which is why ...
(Date:5/2/2015)... It’s a pattern that won’t relent anytime ... on this planet, cyber scammers will immediately be thinking ... their own personal gain. And on April 30, ... issued an alert titled “Nepal Earthquake Disaster Email Scams,” ... earthquake in Nepal. The scam emails may contain links ...
(Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response to the ... offers relief for caregivers by visiting loved ones in nursing ... the Caregiver Action Network, eight in ten caregivers are employed. ... caring for an elderly or disabled loved one. For ... caregiver is now empowered to schedule an on demand visit ...
(Date:5/2/2015)... May 02, 2015 ZoomCare, the Portland-based ... submitted plans to offer its new healthcare insurance to ... ZOOM+ Personal Health Insurance System is the nation’s first ... enhance human performance. ZOOM+ Personal Health Insurance was ZoomCare’s ... system that are subject to review and regulation by ...
Breaking Medicine News(10 mins):Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:ZoomCare Applies to be on Oregon Exchange 2
... , LAS VEGAS, Dec. 8 ... Glen Tullman will host a webcast today, broadcasted live from the ... innovations: Allscripts Professional(TM) EHR 9.0 , a breakthrough in user ... physician groups; and Allscripts Remote (TM) for BlackBerry ® ...
... , OAKLAND, Calif., Dec. 8 ... stress-free and harmonious year. To help people learn to live a ... that it will dedicate 2010 to teaching people how to live ... and integrating one of the Principles, with a year-end intensive program, ...
... 8 Anesiva, Inc. (Nasdaq: ANSV ) announced today ... The NASDAQ Stock Market ("Nasdaq") stating that Anesiva was required ... (MVPHS) of $5,000,000 during the last 30 consecutive business days ... Rule 5450(b)(1)(C). The notification letter has no effect at this ...
... PROVERI, Inc. is pleased to announce that it has been ... Top Innovator award by youngStartup Ventures. The list of privately ... for the Technology, Life Sciences and Clean-tech sectors. , As one ... of PROVERI, Inc., will present the company at the exclusive 2009 ...
... NEW YORK, Dec. 8 Parenting a family of any size ... difference is that in this "second family," the parenting does not ... parents. , According to William Bryan, Ph.D., cofounder of Active ... to define this particular phenomenon that affects 10 million households where ...
... The long ... new features for effectively working with Microsoft Office and high performance 64 bit functionality. ... (PRWEB) December 8, 2009 -- ... 64-bit capability. To date, InfoZoom has been known as one of the fastest ...
Cached Medicine News:Health News:Allscripts Launches New Innovations in Live Event 2Health News:Allscripts Launches New Innovations in Live Event 3Health News:Allscripts Launches New Innovations in Live Event 4Health News:Allscripts Launches New Innovations in Live Event 5Health News:Allscripts Launches New Innovations in Live Event 6Health News:The Breema Center Presents a Yearlong Campaign to Transform Stress into Harmony in 2010 and Beyond 2Health News:Anesiva Receives NASDAQ Listing Compliance Notice 2Health News:Anesiva Receives NASDAQ Listing Compliance Notice 3Health News:PROVERI, Inc. Named a Top Innovator Winner 2Health News:'Sandwich Generation' Avoids Unnecessary Stress While Tending to Aging Senior Parents 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3
... mirrors angled at 76°, 66° and 60°. ... well as central and peripheral fundus viewing and ... angled and spaced 120° apart to eliminate "gaps" ... of the lens also provides direct observation of ...
... For those who prefer the versatility that a ... consider the Volk g-2 trabeculum. It features the ... two opposing mirrors angled at 60 and 64 ... NF (no-flange/no-fluid) design. Volk recommends the "Flanged" model ...
... a family of single-use direct view vitrectomy lenses ... region of the retinal surface during eye surgery. ... gram and is formed and polished to interface ... cornea. Lenses come in boxes of 10 and ...
... Prism are designed for midperipherical ... for tractional retinal detachments (PDR, ... detachment. They can be used ... midperipheral laser applications. Direct image ...
Medicine Products: